Co-Diagnostics, Inc Earning Date (CODX)

USA |NASDAQ |USD

CODX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 25, 2022 (est) Dec 31, 2021 - - $0.45
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 25, 2022 (est) Dec 31, 2021 - - $27.15M

Co-Diagnostics, Inc's next estimated earnings date (based on same quarter last year's date) is Mar 25, 2022 for the fiscal quarter ending Dec 31, 2021.

CODX Earnings Date & History Chart

CODX Earnings & Revenue Forecast

CODX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $0.52 $0.13 $1.07

CODX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $0.52 $0.48 $0.59

CODX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $83.76M $60.27M $118.00M

CODX Earnings Date & Revenue History

CODX Earnings History

|
Show More
Show More

CODX Revenue History

|
Show More
Show More

Co-Diagnostics, Inc Next Earnings Date & Report

CODX Nov 2021 (FQ) Earnings Date & Report Preview

CODX's next estimated earnings date (based on same quarter last year's report date) is Mar 25, 2022 for the fiscal quarter ending Dec 31, 2021.

Co-Diagnostics, Inc Previous Earnings Dates & Reports

CODX Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Co-Diagnostics, Inc's previous earnings date was Nov 15, 2021 for its fiscal quarter ended Sep 30, 2021.

CODX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Co-Diagnostics, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

CODX's earnings per share (EPS) was $1.36, missing the consensus analysts forecast of $1.54 by -11.69% , and higher than the previous year's EPS (Dec 2019) by -477.78%.

Revenues were $74.55M, better than the forecast of $72.37M by 3.02%, and up by 34579.90% from previous year's revenue.

The company reported a net income of $42.48M.

Co-Diagnostics, Inc reported a free cash flow of $27.39M for its fiscal year, compared to $-5.64M a year ago.